Literature DB >> 8063386

Protective effect of rSm28GST-specific T cells in schistosomiasis: role of gamma interferon.

V Pancre1, I Wolowczuk, S Guerret, M C Copin, A Delanoye, A Capron, C Auriault.   

Abstract

Immunization with a single dose of 50 micrograms of recombinant Schistosoma mansoni 28-kDa glutathione-S-transferase (rSm28GST) was able to induce a reduction in the worm burden, the number of eggs, and the degree of hepatic fibrosis as quantified by the measurement of collagen content in the liver of S. mansoni-infected mice. No relationship was found between anti-Sm28GST immunoglobulin G and immunoglobulin A titers and the levels of protection obtained. Adoptive transfers of Sm28GST-specific total, CD4+, or CD8+ T cells reproduced the protective effect obtained with the recombinant molecule. Moreover, experiments studying in vivo T-cell depletion demonstrated that anti-CD4- or anti-CD8-treated mice showed a significant decrease in the protective effect conferred, suggesting a role of the two T-cell subpopulations in the expression of Sm28GST-mediated protection against hepatic damage. Sm28GST-specific cells produced little interleukin-4 and high levels of gamma interferon. Treatment of immunized mice with anti-gamma interferon antibody totally suppressed the Sm28GST-induced protective effect and led to the rapid death of infected animals, suggesting a role for this cytokine in the expression of the protective immunity obtained after immunization with rSm28GST.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8063386      PMCID: PMC303023          DOI: 10.1128/iai.62.9.3723-3730.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Recombinant IL-2 therapy reverses diminished granulomatous responsiveness in anti-L3T4-treated, Schistosoma mansoni-infected mice.

Authors:  R C Mathew; S Ragheb; D L Boros
Journal:  J Immunol       Date:  1990-06-01       Impact factor: 5.422

2.  High-level production of biologically active human alpha 1-antitrypsin in Escherichia coli.

Authors:  M Courtney; A Buchwalder; L H Tessier; M Jaye; A Benavente; A Balland; V Kohli; R Lathe; P Tolstoshev; J P Lecocq
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

3.  Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis.

Authors:  M J Czaja; F R Weiner; S Takahashi; M A Giambrone; P H van der Meide; H Schellekens; L Biempica; M A Zern
Journal:  Hepatology       Date:  1989-11       Impact factor: 17.425

4.  Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection.

Authors:  D W Dunne; A E Butterworth; A J Fulford; H C Kariuki; J G Langley; J H Ouma; A Capron; R J Pierce; R F Sturrock
Journal:  Eur J Immunol       Date:  1992-06       Impact factor: 5.532

5.  Regulation of granulomatous inflammation in murine schistosomiasis. IV. Antigen-induced suppressor T cells down-regulate proliferation and IL-2 production.

Authors:  P L Fidel; D L Boros
Journal:  J Immunol       Date:  1990-08-15       Impact factor: 5.422

6.  A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections.

Authors:  A López-De León; M Rojkind
Journal:  J Histochem Cytochem       Date:  1985-08       Impact factor: 2.479

7.  The molecular basis of granuloma formation in schistosomiasis. I. A T cell-derived suppressor effector factor.

Authors:  P J Perrin; S M Phillips
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

8.  In vivo T cell depletion regulates resistance and morbidity in murine schistosomiasis.

Authors:  S M Phillips; G P Linette; B L Doughty; J E Byram; F Von Lichtenberg
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

9.  IgA antibodies to a protective antigen in human Schistosomiasis mansoni.

Authors:  J M Grzych; D Grezel; C B Xu; J L Neyrinck; M Capron; J H Ouma; A E Butterworth; A Capron
Journal:  J Immunol       Date:  1993-01-15       Impact factor: 5.422

10.  Characterization of granuloma T lymphocyte function from Schistosoma mansoni-infected mice.

Authors:  S Ragheb; D L Boros
Journal:  J Immunol       Date:  1989-05-01       Impact factor: 5.422

View more
  12 in total

1.  Schistosomal egg antigen-responsive CD8 T-cell population in Schistosoma mansoni-infected BALB/c mice.

Authors:  V Pancré; M Delacre; J Herno; C Auriault
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

2.  SjTat-TPI facilitates adaptive T-cell responses and reduces hepatic pathology during Schistosoma japonicum infection in BALB/c mice.

Authors:  Wenyue Zhang; Xiaofeng Luo; Fan Zhang; Yuxiao Zhu; Bingya Yang; Min Hou; Zhipeng Xu; Chuanxin Yu; Yingying Chen; Lin Chen; Minjun Ji
Journal:  Parasit Vectors       Date:  2015-12-30       Impact factor: 3.876

3.  HLA class II polymorphism influences onset and severity of pathology in Schistosoma mansoni-infected transgenic mice.

Authors:  G Angyalosi; R Neveu; I Wolowczuk; A Delanoye; J Herno; C Auriault; V Pancré
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

4.  Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B.

Authors:  Ping Liu; Yi-Yang Hu; Cheng Liu; Da-Yuan Zhu; Hui-Ming Xue; Zhi-Qiang Xu; Lie-Ming Xu; Cheng-Hai Liu; Hong-Tu Gu; Zhi-Qing Zhang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

5.  DNA vaccination by electroporation and boosting with recombinant proteins enhances the efficacy of DNA vaccines for Schistosomiasis japonica.

Authors:  Yang Dai; Yinchang Zhu; Donald A Harn; Xiaoting Wang; Jianxia Tang; Song Zhao; Fei Lu; Xiaohong Guan
Journal:  Clin Vaccine Immunol       Date:  2009-10-07

6.  Immunogenicity of genetically engineered glutathione S-transferase fusion proteins containing a T-cell epitope from diphtheria toxin.

Authors:  S Pillai; K Dermody; B Metcalf
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

7.  Immune events associated with high level protection against Schistosoma japonicum infection in pigs immunized with UV-attenuated cercariae.

Authors:  Fang Tian; Dandan Lin; Jingjiao Wu; Yanan Gao; Donghui Zhang; Minjun Ji; Guanling Wu
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

8.  The nature and combination of subunits used in epitope-based Schistosoma japonicum vaccine formulations affect their efficacy.

Authors:  Xuefeng Wang; Lei Zhang; Ying Chi; Jason Hoellwarth; Sha Zhou; Xiaoyun Wen; Lei He; Feng Liu; Calvin Wu; Chuan Su
Journal:  Parasit Vectors       Date:  2010-11-19       Impact factor: 3.876

9.  Upregulated expression of cytotoxicity-related genes in IFN-γ knockout mice with Schistosoma japonicum infection.

Authors:  Xiaotang Du; Jingjiao Wu; Meijuan Zhang; Yanan Gao; Donghui Zhang; Min Hou; Minjun Ji; Guanling Wu
Journal:  J Biomed Biotechnol       Date:  2011-10-01

Review 10.  Eliminating Schistosomes through Vaccination: What are the Best Immune Weapons?

Authors:  Cristina Toscano Fonseca; Sergio Costa Oliveira; Clarice Carvalho Alves
Journal:  Front Immunol       Date:  2015-03-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.